Skip to content
DefDex

Federal award

DIAGNOSTICA STAGO INC

W81K0023P0032

Contract

Obligated and Ceiling

Obligated (net)
$817,019.02
Ceiling (potential value, not spending)
$1,247,820.27
Current value
$1,121,114.02
Gross positive obligations
$931,945.07

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DIAGNOSTICA STAGO INC · ND7MY2A4ZUE9
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
DIAGNOSTICA STAGO INC · ND7MY2A4ZUE9
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0023P0032
Award type code
B
Actions
15 · Dec 16, 2022 to Jun 18, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 18, 2026FY2026P00014G$0.00
—
Mar 5, 2026FY2026P00013M$280,862.14
—
Jul 15, 2025FY2025P00012G$0.00
—
Jun 10, 2025FY2025P00011M$0.00
—
Mar 24, 2025FY2025P00010D$0.00
—
Dec 13, 2024FY2025P00009C$256,957.20
—
Aug 14, 2024FY2024P00008G$0.00
—
Aug 7, 2024FY2024P00007B$0.00
—
Feb 16, 2024FY2024P00006C$210,548.68
—
Nov 17, 2023FY2024P00005C$45,665.79
—
Sep 6, 2023FY2023P00004G$0.00
—
Jun 30, 2023FY2023P00003B−$45,970.42
—
Apr 17, 2023FY2023P00002B−$68,955.63
—
Feb 15, 2023FY2023P00001C$137,911.26
—
Dec 16, 2022FY20230—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.